Medication info
Itrafen Tablets

Itrafen Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
White BioScience Co., Ltd.
Appearance
Pale yellow oblong film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201309487 · Approved 2013.09.30 · Insurance code 625200220

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to elderly patients 75 years of age or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, it is not necessary to readminister this drug after dialysis to maintain analgesic effect. Patients with hepatic impairment In patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children 12 years of age or older: Adjust the dose according to the patient's pain severity and response to treatment. The recommended initial dose is 2 tablets. Thereafter, doses should be administered at intervals of at least 6 hours, and the total dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this drug should be continued.

Ingredients

Manufacturer
White BioScience Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to elderly patients 75 years of age or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, it is not necessary to readminister this drug after dialysis to maintain analgesic effect. Patients with hepatic impairment In patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children 12 years of age or older: Adjust the dose according to the patient's pain severity and response to treatment. The recommended initial dose is 2 tablets. Thereafter, doses should be administered at intervals of at least 6 hours, and the total dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this drug should be continued.

Precautions

This medication can put strain on the liver, so individuals who regularly consume more than three drinks a day should consult with their doctor or pharmacist before taking it. Due to the acetaminophen component, serious skin reactions may occur very rarely, so if skin rashes or allergic reactions occur, use should be discontinued immediately. The tramadol component can increase the risk of seizures, so patients with a history of seizures or risk factors for seizures should exercise special caution. Additionally, taking this medication along with certain antidepressants, opioid analgesics, or MAO inhibitors can further increase the risk of seizures, so concurrent use should be avoided or discussed with a doctor. There is a rare possibility of serious allergic reactions, so any symptoms like difficulty breathing or hives should be reported to medical personnel immediately. Patients with acute and severe bronchial asthma may experience severe respiratory depression when taking this medication, so it should be administered with monitoring in a medical facility. This medication can cause severe drowsiness, respiratory depression, and coma when taken with central nervous system depressants or alcohol, so caution is needed. Patients with increased intracranial pressure or head injuries may experience worsening symptoms due to respiratory depression, so usage should be cautious. This medication can cause dependency similar to morphine, thus long-term use requires careful monitoring of potential dependency. Patients with poor liver function or liver disorders may face risks of liver damage, thus consulting with a doctor before use is necessary. Especially for ultra-rapid CYP2D6 metabolizers, the medication may metabolize faster than expected, increasing the risk of respiratory depression, thus caution is warranted. Children under 12 years or individuals under 18 who have undergone tonsillectomy or adenoidectomy should not be administered this medication. Patients with sleep apnea or at risk for hypoxia need continuous assessment as their symptoms may worsen with this medication. Elderly patients or those at risk for hyponatremia may experience symptoms of hyponatremia, thus monitoring is necessary. This medication should not be administered to those with hypersensitivity to specific components, severe respiratory depression, central nervous system drug poisoning, or severe dysfunction of liver, kidney, or heart. The recommended dosage must be strictly adhered to, and it should not be taken with other tramadol or acetaminophen products. Abruptly discontinuing the medication may result in withdrawal symptoms, so it should be tapered down according to a doctor's instructions. This medication can induce drowsiness or dizziness when driving or operating machinery, so caution is required. In case of overdose, serious side effects like respiratory depression, seizures, or liver damage can occur, and immediate emergency treatment should be sought. During the course of this medication, it is important to consult with a physician and promptly report any abnormal symptoms to receive treatment.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, death, carbon dioxide retention, respiratory inhibition, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, hives, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, excitement, abnormal dreams, substance abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormalities, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, hot flashes, weight loss, increased serum creatinine, anaphylactic response, Stevens-Johnson syndrome, toxic epidermal necrolysis, influence on emotional instability, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hypoprothrombinemia, pyruvate acidemia, hyponatremia, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exacerbation of migraine, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function values, oliguria, rash, increased sweating, hives, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, decreased appetite, anxiety, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, arrhythmia, worsening hypertension, aortic stenosis, bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory tract syndrome, oral dryness, excitement, nervousness, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system response, hives, rash, bronchospasm, toxic skin necrosis, allergic reaction, paralytic ileus, cholecystitis, abnormal kidney function values, increased salivation, bleeding, withdrawal symptoms, insomnia, decreased appetite, anxiety, nervousness, emotional instability, hallucinations, depersonalization, drowsiness, substance abuse, hallucinations, withdrawal syndrome, seizures, serotonin syndrome, respiratory arrest, QT prolongation, abdominal discomfort, nausea, lethargy, pallor, increased sweating, symptoms of acute or chronic adrenal insufficiency, opioid-induced hyperalgesia, withdrawal syndrome, excessive sedation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture from entering. Additionally, it is best to keep the medication at room temperature between 1 to 30 degrees Celsius. This helps maintain the effectiveness of the medication over time.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.